Issue: 2012 April 2

First Friday Artists Market debuts on Homewood campus

April 5, 2012

The Levering Hall patio will explode with hues and creativity this Friday as a new monthly student-run event kicks off on the Homewood campus. The First Friday Artists Market provides a venue for student artists to sell their paintings, photography, pottery, sculptures, calligraphy and any other original pieces. The event, sponsored by the Student Government […]

Obese white women less likely to seek colon cancer screening

April 4, 2012

A new study by Johns Hopkins researchers shows that obese white women may be less likely than normal-weight counterparts and African-Americans of any weight or gender to seek potentially lifesaving colon cancer screening tests. Results of this study follow the same Johns Hopkins group’s previous research suggesting that obese white women also are less likely to […]

Hot Jobs — April 2, 2012

April 3, 2012

Homewood Office of Human Resources Wyman Park Building, Suite W600 410-516-7196 The Reporting Specialist and Special Projects position is located within Human Resources/Payroll Shared Services and will serve as the SAP reporting expert responsible for supporting the functional SAP processes and procedures as related to HR/Payroll Shared Services, which is a high-volume call center. The […]

New dean introduced at SAIS

April 2, 2012

Vali Nasr leads something of a double life. Triple, actually. There is Nasr the academic, a highly regarded teacher and scholar on Iran, the Middle East and the Islamic world. He has written eight books and played a leadership role on the school and university levels. And there is Nasr the counselor, consulted on foreign […]

Johns Hopkins first in R&D expenditures for 32nd year

April 2, 2012

The Johns Hopkins University performed $2 billion in medical, science and engineering research in fiscal 2010, making it the leading U.S. academic institution in total research and development spending for the 32nd year in a row, according to a new National Science Foundation ranking. The university also once again ranked first on the NSF’s separate […]

Undergrad tuitions set for 2012–13

April 2, 2012

Tuition for full-time liberal arts and engineering undergraduates at Johns Hopkins will increase 3.9 percent this fall, the fourth consecutive increase below 4 percent. The increase, amounting to $1,650, will bring 2012–13 tuition to $43,930 for the more than 5,000 full-time undergraduates in the university’s Krieger School of Arts and Sciences and Whiting School of […]

Applications hit a record high, admissions a record low

April 2, 2012

For the 10th year in a row, a record-breaking number of people—20,496—applied for undergraduate admission to the schools of Arts and Sciences and Engineering at The Johns Hopkins University, a 5 percent increase over last year. At the same time, the university’s admissions rate fell to a record low: Only 17.7 percent of those applying […]

New early warning system for seizures

April 2, 2012

Epilepsy affects 50 million people worldwide, and in a third of these cases, medication cannot keep seizures from occurring. One solution is to shoot a short pulse of electricity to the brain to stamp out the seizure just as it begins to erupt. But brain implants designed to do this have run into a stubborn […]

JHU artist in residence to perform at BMA

April 2, 2012

Mezzo-soprano Stephanie McGuire will present a free performance of her solo operatic theater piece, Mezzo Laid Bare, at 7 p.m. on Thursday, April 5, in the auditorium of the Baltimore Museum of Art. McGuire is visiting The Johns Hopkins University’s Homewood campus this spring as the 2012 artist in residence with the Krieger School’s Center […]

Newly discovered foot points to new kid on the hominin block

April 2, 2012

It seems that “Lucy” was not the only hominin on the block in northern Africa about 3 million years ago. A team of researchers that included Johns Hopkins University geologist Naomi Levin has announced the discovery of a partial foot skeleton with characteristics (such as an opposable big toe bone) that don’t match those of […]

Dengue virus turns on mosquito genes that make them hungrier

April 2, 2012

Researchers at the Johns Hopkins Bloomberg School of Public Health have, for the first time, shown that infection with dengue virus turns on mosquito genes that make them hungrier and better feeders, and therefore possibly more likely to spread the disease to humans. Specifically, they found that dengue virus infection of the mosquito’s salivary gland […]

Genetic risk, stressful infancy join to increase schizophrenia risk

April 2, 2012

Working with genetically engineered mice and the genomes of thousands of people with schizophrenia, researchers at Johns Hopkins say they now better understand how both nature and nurture can affect one’s risks for schizophrenia and abnormal brain development in general. The researchers reported in the March 2 issue of Cell that defects in schizophrenia-risk genes […]

Scientists reprogram cancer cells with low doses of epigenetic drugs

April 2, 2012

Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) and decitabine (DAC), are epigenetic-targeted drugs and work to correct cancer-causing alterations that modify DNA. The researchers said that the drugs also […]

Hospitals with no cardiac surgery can perform nonemergency angioplasty

April 2, 2012

Patients who have nonemergency angioplasty to open blocked heart vessels have no greater risk of death or complications when they have the procedure at hospitals without cardiac surgery backup. That is the conclusion of a national study to assess the safety and effectiveness of such procedures at community hospitals. Results of the study, called the […]

Report: Brain cancer blood vessels not substantially tumor-derived

April 2, 2012

Johns Hopkins scientists have published laboratory data refuting studies that suggest blood vessels that form within brain cancers are largely made up of cancer cells. The theory of cancer-based blood vessels calls into question the use and value of anti-cancer drugs that target these blood vessels, including bevacizumab (Avastin). “We don’t question whether brain cancer […]

Next Page »